SDS

SAFETY DATA SHEET
Page 3 of 6
WSP-001
Prepared to OSHA, ACC, ANSI, NOHSC, WHMIS, 2001/58 & 1272/2008/EC Standards SDS Revision: 3.0 SDS Revision Date: 1/22/2014
8. EXPOSURE CONTROLS & PERSONAL PROTECTION
8.1 Ventilation & Engineering Controls:
Use with adequate ventilation (e.g., local exhaust ventilation is preferred, fans, open doors and windows). Use in a
chemical fume hood when working with large quantities of product and provide adequate ventilation (e.g., local
exhaust ventilation, fans). Ensure that an eyewash station, sink or washbasin is available in case of exposure to
eyes.
8.2 Respiratory Protection:
No special respiratory protection is required under typical circumstances of use or handling.
If necessary, use only respiratory protection authorized per U.S. OSHA's requirement in 29
CFR §1910.134, or applicable U.S. state regulations, or the appropriate standards of
Canada, its provinces, E.C. member states, or Australia.
8.3 Eye Protection:
Avoid eye contact. Safety glasses with side shields should be used when handling large
quantities (e.g., > 10 lbs (4.5 kg)) of this product. If necessary, refer to U.S. OSHA 29 CFR
§1910.133, Canadian standards, or the European Standard EN166.
8.4 Hand Protection:
None required under normal conditions of use. However, may cause skin irritation and/or
allergic sensitivity in some sensitive individuals, so when product is being mixed, or handled,
wear gloves made of latex, rubber (nitrile), vinyl or other impervious material. If anticipated
that prolonged & repeated skin contact will occur during use of this product, wear latex,
rubber (nitrile), vinyl or other impervious gloves. If necessary, refer to U.S. OSHA 29 CFR
§1910.138, the appropriate standards of Canada, of the E.C. member states.
8.5 Body Protection:
No special body protection is required under typical circumstances of use and handling. If
necessary, refer to appropriate standards of Canada, the E.C. member states, or U.S. OSHA.
9. PHYSICAL & CHEMICAL PROPERTIES
9.1 Appearance:
White
9.2 Odor:
Waxy solid with slight petroleum odor
9.3 Odor Threshold:
ND
9.4 pH:
NA
9.5 Melting Point/Freezing Point:
NE
9.6 Initial Boiling Point/Boiling Range:
> 60 °C
9.7 Flashpoint:
NA
9.8 Upper/Lower Flammability Limits:
NE
9.9 Vapor Pressure:
132 Pa
9.10 Vapor Density:
NA
9.11 Relative Density:
0.8 g/mL
9.12 Solubility:
Insoluble
9.13 Partition Coefficient (log P
ow
):
NA
9.14 Autoignition Temperature:
> 200 °C
9.15 Decomposition Temperature:
NA
9.16 Viscosity:
NA
9.17 Other Information:
NA
10. STABILITY & REACTIVITY
10.1 Stability:
This product is stable under ambient conditions when stored properly (see Section 7, Storage and Handling).
10.2 Hazardous Decomposition Products:
Oxides of carbon (CO, CO
2
) and sulfur (SO
2
).
10.3 Hazardous Polymerization:
May occur, if exposed to extremely high temperatures.
10.4 Conditions to Avoid:
Open flames, sparks, high heat and direct sunlight.
10.5 Incompatible Substances:
This product is incompatible with strong oxidizers (e.g., peroxides, superoxides), strong acids (e.g., hydrochloric or
muriatic acids), strong bases (e.g., lye, potassium hydroxide).
11. TOXICOLOGICAL INFORMATION
11.1 Routes of Entry: Inhalation:
YES
Absorption:
YES
Ingestion:
YES
11.2 Toxicity Data:
The product has NOT been tested on animals to obtain toxicological data. There are toxicology data for the
components of this product, which are found in the scientific literature, but this data has not been presented in this
document. Calculated LD
50
: > 7,674 mg/L; LD
50
: > 3,981 mg/kg.
11.3 Acute Toxicity:
See section 2.5
11.4 Chronic Toxicity:
See section 2.6
11.5 Suspected Carcinogen:
NA
11.6 Reproductive Toxicity:
This product is not reported to produce reproductive toxicity in humans.
Mutagenicity:
This product is not reported to produce mutagenic effects in humans.
Embryotoxicity:
This product is not reported to produce embryotoxic effects in humans.
Teratogenicity:
This product is not reported to produce teratogenic effects in humans.
Reproductive Toxicity:
This product is not reported to produce reproductive effects in humans.
11.7 Irritancy of Product:
See Section 2.3
11.8 Biological Exposure Indices:
NE
11.9 Physician Recommendations:
Treat symptomatically.